Bridging the gap between academic IP and technology commercialization.


KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.


KensaGroup co-founder Tony Eisenhut discusses successful characteristics of entrepreneurs.

KensaGroup co-founder Bruce Ganem discusses the diferent challenges scientists face in product invention versus execution of a company.

Latest News

06.19.17 - GNS Healthcare announces collaboration with Genentech for development of novel cancer therapies ...more

06.07.17 - Grainful closes $3.3million round of financing as Americans embrace savory oats...more

04.04.17 - GNS taps nationally regarded epidemiologist to put discoveries from causal machine learning and simulation platform in clinical context ...more

03.03.17 - Tukek Holding leads new biorefinery complex in Adana that will incorporate Novomer technology ...more

02.27.17 - Supercritical Carbon Dioxide–Based Sterilization of Decellularized Heart Valves...more

01.30.17 - Men's Journal chooses Grainful entrees as healthy and delicious...more

01.26.17 - Grainful launches three new frozen entree flavors...more


KensaGroup, LLC

2415 N. Triphammer Road

Ithaca, NY 14850

phone: 1.607.330.2307

Fax: 1.607.330.2319